Delirium: Recognition, Assessment, and Management

Delirium is an acute medical syndrome characterized by disturbed consciousness, fluctuating mental status, and inattention, often precipitated by underlying systemic illness or medication. Despite being the most common psychiatric complication of general medical illness and hospitalization, delirium remains underrecognized and inadequately managed in many clinical settings. This comprehensive review synthesizes current evidence on delirium epidemiology, pathophysiology, diagnostic assessment, and evidence-based management strategies for acute and general medical care professionals.

Introduction: Delirium as a Medical Emergency

Delirium is a medical syndrome—not a disease itself—reflecting acute global brain dysfunction. The term encompasses a final common pathway of multiple medical, surgical, and psychiatric etiologies manifesting as acute inattention, disorganized thinking, and altered consciousness. Modern understanding recognizes delirium as a medical emergency requiring urgent identification of precipitants and aggressive management.

The high prevalence, diagnostic complexity, and substantial morbidity and mortality associated with delirium necessitate sophisticated clinical approaches. This review provides clinicians with evidence-based frameworks for recognition, differential diagnosis, risk stratification, and multimodal management.

Historical Context and Evolution of Delirium Recognition

Ancient and Classical Period

Descriptions of acute mental disturbance consistent with delirium appear throughout classical medical literature. Hippocratic physicians recognized the prognostic significance of acute mental status changes in febrile illness. Galen documented the distinction between mania (sustained altered behavior) and delirium (acute fluctuating confusion), establishing early nosological differentiation.

Modern Psychiatric Era

The 19th and early 20th centuries witnessed systematic clinical description of acute confusional states. Kraepelin distinguished delirium from primary psychiatric illness, emphasizing its association with medical conditions. However, delirium was often relegated to medical services and overlooked by psychiatry until recently, creating a historical therapeutic gap in psychiatric care of delirious patients.

DSM-5 Diagnostic Criteria and Clinical Definition

The DSM-5 defines delirium as a neurobehavioral syndrome with five core diagnostic criteria that must be present together:

Types and Subtypes of Delirium

Psychomotor Subtyping

Delirium is classified into three psychomotor subtypes based on level of alertness and activity:

Etiological Categories

Delirium manifests from diverse physiological derangements. Common etiological categories include:

• Infections: Pneumonia, UTI, sepsis, meningitis, encephalitis
• Medication effects: Anticholinergics, benzodiazepines, opioids, corticosteroids, anticonvulsants
• Metabolic derangement: Hyponatremia, hypercalcemia, hypoglycemia, hepatic encephalopathy, uremia
• Hypoxia/hypotension: Cardiac failure, pulmonary embolism, anemia, shock states
• CNS insult: Stroke, TIA, ICH, seizures, trauma, anoxia
• Substance intoxication/withdrawal: Alcohol, benzodiazepines, anticholinergics
• Surgical/procedural stress: Postoperative delirium, particularly after cardiac and orthopedic surgery
• Environmental factors: Sleep deprivation, sensory deprivation, ICU setting, immobility

Neurobiological Mechanisms of Delirium

The Cholinergic Hypothesis

The most well-supported mechanistic framework centers on cholinergic deficiency. Multiple lines of evidence implicate reduced acetylcholine availability at cortical and thalamic cholinergic receptors as central to delirium pathogenesis:

• Anticholinergic medications reliably precipitate or worsen delirium
• Cholinesterase inhibitors (physostigmine, donepezil) may reverse delirium
• Inflammation reduces cholinergic tone via microglial activation
• Aging is associated with reduced cholinergic neuronal density and function

Inflammatory and Cytokine Mechanisms

Systemic and neuroinflammatory processes contribute substantially to delirium pathogenesis. Peripheral infections or inflammatory conditions activate microglial cells, which release pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) that disrupt the blood-brain barrier and impair glutamatergic and GABAergic neurotransmission. Elevated cerebrospinal fluid cytokine concentrations correlate with delirium severity.

Monoamine Dysregulation

Delirium involves excess dopaminergic and serotonergic activity and relative GABAergic insufficiency. Dopaminergic hyperactivity particularly characterizes hyperactive delirium, while reduced dopamine may underlie hypoactive presentations. Serotonergic dysregulation contributes to perceptual disturbance and affective instability.

Thalamocortical Disruption

The thalamus serves as a critical relay station for attentional filtering. Delirium involves impaired thalamocortical connectivity and disrupted gating mechanisms, preventing effective sensory filtering and integration. This mechanistic understanding explains the prominence of inattention, disorganization, and perceptual disturbance across delirium presentations.

Critical Differential Diagnosis: Parsing Delirium from Confounders

Accurate differentiation from superficially similar conditions is essential for appropriate management. The following represents the most clinically relevant differential considerations:

Catatonia as Delirium Mimic

Catatonia—characterized by psychomotor immobility, waxy flexibility, mutism, or negativism—represents a distinct neuropsychiatric syndrome often overlooked in delirium assessment. While catatonia frequently co-occurs with medical illness (particularly in ICU settings), it differs from delirium in maintaining relatively preserved consciousness and awareness, despite profound psychomotor abnormality. The Bush-Francis Catatonia Rating Scale facilitates diagnostic distinction. Critically, catatonic features may be primary psychiatric phenomena or secondary to neuroleptic malignant syndrome—requiring careful syndromal parsing.

Delirium Assessment and Screening Tools

Systematic assessment tools dramatically improve delirium detection. The following represent evidence-based instruments applicable across clinical settings:

Confusion Assessment Method (CAM)

The CAM remains the gold-standard screening tool for delirium in non-ICU settings. Diagnostic algorithm requires:

Other Assessment Instruments

Non-Pharmacological Management of Delirium

Evidence strongly supports multicomponent, non-pharmacological interventions as first-line treatment for delirium. The Hospital Elder Life Program (HELP) and similar approaches consistently reduce delirium incidence and severity.

Key Non-Pharmacological Strategies

Pharmacological Management of Delirium

While non-pharmacological approaches form the cornerstone of delirium management, pharmacotherapy is indicated when patients pose danger to themselves or others, or when behavioral symptoms prevent medical care. Current evidence supports selective use of antipsychotics as first-line agents, with other classes reserved for specific clinical scenarios.

Antipsychotics in Delirium: Evidence and Clinical Approach

The role of antipsychotics in delirium has become increasingly nuanced. Recent high-quality evidence (particularly the MIND-USA and PRE-DELIRIUM trials) suggests that routine antipsychotic use may not improve outcomes and can increase adverse effects. However, antipsychotics remain appropriate for specific indications:

Antipsychotic Selection and Dosing

When antipsychotics are indicated, evidence supports the following approach:

Alternative Pharmacological Agents

For specific delirium subtypes or situations, alternative agents merit consideration:

• Cholinesterase inhibitors (donepezil, physostigmine): Emerging evidence supports these for delirium, particularly in cases with profound cholinergic insufficiency. Physostigmine 1-2 mg IV may provide rapid reversal of anticholinergic delirium.
• Benzodiazepines: Limited role; primarily for alcohol/benzodiazepine withdrawal delirium or adjunctive sedation in ICU. Avoid as monotherapy due to paradoxical worsening.
• Dexmedetomidine: Alpha-2 agonist providing sedation with preserved cognition; emerging favorable data in ICU delirium with less delirium-prolonging effects than propofol.
• Methylphenidate: Stimulant useful for hypoactive delirium in specific contexts (minimal metabolic derangement, adequate renal/cardiac function).

Antipsychotic Decision Tree

Medications that Precipitate or Worsen Delirium

Deprescribing Strategy in Delirium

One of the highest-yield interventions in delirium management is systematic medication review and deprescribing. A logical approach includes:

1. List all current medications with start dates and indications
2. Identify medications with anticholinergic or CNS-depressant properties
3. Assess necessity of each medication given acute medical situation
4. Prioritize discontinuation of medications with highest delirium risk and lowest acute necessity
5. Taper long-acting agents gradually where appropriate (benzodiazepines, some anticonvulsants)
6. Monitor closely for withdrawal syndromes (alcohol, benzodiazepines)

Natural Course, Resolution, and Prognostic Factors

Temporal Trajectory

Delirium typically follows a characteristic temporal pattern:

Factors Influencing Recovery Timeline

Duration and resolution of delirium depend on multiple factors:

Long-Term Consequences

Growing evidence indicates that delirium, particularly severe or prolonged episodes, carries lasting cognitive and functional consequences beyond the acute illness. Post-delirium cognitive impairment may persist for months to years, manifesting as executive dysfunction, memory deficits, and processing slowing even after full medical recovery. ICU survivors with delirium show accelerated cognitive decline in subsequent years and increased dementia risk. Psychological consequences include PTSD-like symptoms, anxiety, depression, and reduced quality of life. These observations underscore the importance of aggressive delirium prevention and treatment, with long-term neuropsychological follow-up for severe cases.

Delirium Prevention: The HELP Protocol and Evidence-Based Strategies

Primary prevention of delirium offers substantial advantages over management of established disease. The Hospital Elder Life Program (HELP) demonstrates 30-40% reduction in incident delirium through systematic, multicomponent intervention.

Specific Prevention Strategies by Risk Group

Older adults undergoing elective surgery: Preoperative cognitive assessment, medication review, family involvement in perioperative planning, post-operative early mobilization, avoidance of benzodiazepine premedication

Hospitalized elderly without acute delirium: Daily CAM screening, proactive HELP protocol elements, medication deprescribing, infection/metabolic monitoring

ICU patients: Daily sedation interruption trials, spontaneous breathing trials, early mobilization within hemodynamic tolerance, delirium assessment via CAM-ICU, medication optimization

Patients with dementia or delirium history: Intensive non-pharmacological preventive measures, family/caregiver presence, familiar environmental cues, medication vigilance

Key Clinical Learning Points: Summary

References and Further Reading

1. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941-948.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
3. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703-2710.
4. Girard TD, Jackson JC, Pandharipande PP, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513-1520.
5. Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older adults. N Engl J Med. 1999;340(9):669-676.
6. Flaherty JH, Steeves BL. Complicated delirium: when more than the most common precipitants are involved. Am Fam Physician. 2000;61(4):1033-1040.
7. Breitbart W, Alici Y. Agitation and delirium at the end of life: "We couldn't manage him." JAMA. 2008;300(24):2898-2910.
8. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104(1):21-26.
9. Saxena S, Lawley D. Delirium in the elderly: a practical approach. Postgrad Med J. 2009;85(1009):642-651.
10. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.
11. Grover S, Avasthi A, Sharma A. Delirium: a review of literature. J Neurosci Rural Pract. 2011;2(1):60-66.
12. MacLullich AM, Beaglehole A, Hall RJ, et al. Delirium and long-term function in older people after hospitalization. Age Ageing. 2017;46(4):690-696.
13. Hshieh TT, Yue J, Oh E, et al. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015;175(4):512-520.
14. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016;(3):CD005563.
15. Al-Qadheeb NS, Skrobik Y. Preventing delirium in the critically ill. Expert Rev Respir Med. 2010;4(3):395-408.
16. van Dyck CH, Albers JW, Alessi CA, et al. Delirium in older hospitalized patients: evaluation and management. J Am Geriatr Soc. 1999;47(4):450-456.
17. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753-1762.
18. Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med. 2011;364(15):1456-1465.
19. Siddiqi N, Stockdale R, Britton AM, et al. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev. 2007;(2):CD005563.
20. Davis DH, Muniz Terrera G, Keage H, et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135(Pt 9):2809-2816.